Apelanio, Mark John S.

HRN: 16-91-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
CO-AMOXICLAV 625MG (TAB)
01/08/2023
01/14/2023
PO
625
BID
Abrasions
Waiting Final Action 
01/08/2023
MUPIROCIN 2%, 15G (TUBE)
01/08/2023
01/14/2023
TOPICAL
5%
BID
Abrasion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: